Characterization of β2-Adrenergic Receptor Dephosphorylation: Comparison with the Rate of Resensitization

Dephosphorylation of the cyclic AMP-dependent protein kinase (PKA) site phosphoserine 262 and the G protein-coupled receptor kinase (GRK) site phosphoserines 355 and 356 of the β2-adrenergic receptor (β2AR) were characterized in both intact human embryonic kidney 293 cells and subcellular fractions and were correlated with the rate of resensitization of isoproterenol stimulation of adenylyl cyclase after treatment with isoproterenol and blockade by antagonist. Dephosphorylation of the PKA site after stimulation with 300 pM isoproterenol occurred with a t½ of 9 min (k = 0.08 ± 0.016/min) in intact cells in the absence of internalization. Dephosphorylation of the GRK sites in intact cells after treatment with 1.0 μM isoproterenol for 5 min exhibited a lag phase of ≈ 5 min, after which dephosphorylation proceeded slowly with a t½ of 18 min (k = 0.039 ± 0.006/min). Consistent with the slow rate of GRK site dephosphorylation, the phosphatase inhibitors calyculin A and okadaic acid failed to augment phosphorylation in intact cells during continuous agonist stimulation indicating that GRK site dephosphorylation was minimal. However, both inhibited dephosphorylation of the GRK sites after the addition of antagonist. Slow GRK site dephosphorylation after antagonist treatment was also demonstrated by the relative stability of internalized phosphorylated β2AR in cells as observed both by immunofluorescence microscopy using a phospho-site-specific antibody and by studies of the subcellular localization of the GRK-phosphorylated β2AR on sucrose gradients that revealed nearly equivalent levels of GRK site phosphorylation in the plasma membrane and vesicular fractions. In addition, dephosphorylation of the GRK sites by intrinsic phosphatase activity occurred only in the heavy vesicle fractions. In contrast to the slow rates of dephosphorylation, the rate of resensitization of isoproterenol stimulation of adenylyl cyclase was 5- and 10-fold faster (k = 0.43 ± 0.009/min; t½ = 1.6 min), than PKA and GRK site dephosphorylation, respectively, clearly dissociating the rapid phase of resensitization (0-5 min) from dephosphorylation.

[1]  G. Milligan,et al.  Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors. , 2000, British journal of pharmacology.

[2]  B. J. Knoll,et al.  Partial agonists and G protein-coupled receptor desensitization. , 1999, Trends in pharmacological sciences.

[3]  M. Lohse,et al.  Binding of purified recombinant beta-arrestin to guanine-nucleotide-binding-protein-coupled receptors. , 1995, European journal of biochemistry.

[4]  V. Gurevich,et al.  The molecular acrobatics of arrestin activation. , 2004, Trends in pharmacological sciences.

[5]  A. Burlingame,et al.  Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. , 2005, Biochemistry.

[6]  M. Caron,et al.  Inhibition of beta-adrenergic receptor kinase prevents rapid homologous desensitization of beta 2-adrenergic receptors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Friedman,et al.  Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. , 2004, Molecular pharmacology.

[8]  J L Benovic,et al.  Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Caron,et al.  Cellular Trafficking of G Protein-coupled Receptor/β-Arrestin Endocytic Complexes* , 1999, The Journal of Biological Chemistry.

[10]  M. Caron,et al.  Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. , 1990, The Journal of biological chemistry.

[11]  P. Molinoff,et al.  Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors. , 1986, The Journal of pharmacology and experimental therapeutics.

[12]  L. Birnbaumer,et al.  Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. , 1994, Molecular pharmacology.

[13]  N. Prashad,et al.  Epinephrine-induced sequestration of the beta-adrenergic receptor in cultured S49 WT and cyc- lymphoma cells. , 1985, Journal of cyclic nucleotide and protein phosphorylation research.

[14]  Martin J. Lohse,et al.  β-Arrestin Binding to the β2-Adrenergic Receptor Requires Both Receptor Phosphorylation and Receptor Activation* , 2005, Journal of Biological Chemistry.

[15]  R Barber,et al.  Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution. , 1996, Molecular pharmacology.

[16]  J. Friedman,et al.  Desensitization of β2-Adrenergic Receptors with Mutations of the Proposed G Protein-coupled Receptor Kinase Phosphorylation Sites* , 1998, The Journal of Biological Chemistry.

[17]  D. Stickle,et al.  Estimation of the kinetic constants for binding of epinephrine to beta-adrenergic receptors of the S49 cell. , 1991, Biochemical pharmacology.

[18]  Eamonn Kelly,et al.  G‐protein‐coupled receptor dephosphorylation at the cell surface , 2006, British journal of pharmacology.

[19]  Kristina Lorenz,et al.  Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. , 2005, The Journal of biological chemistry.

[20]  P. Fishman,et al.  Differences in endosomal targeting of human β1- and β2-adrenergic receptors following clathrin-mediated endocytosis , 2004, Journal of Cell Science.

[21]  Hsien-yu Wang,et al.  AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes. , 2004, The Biochemical journal.

[22]  R. Lefkowitz,et al.  Receptor-specific Ubiquitination of β-Arrestin Directs Assembly and Targeting of Seven-transmembrane Receptor Signalosomes* , 2005, Journal of Biological Chemistry.

[23]  John D. Scott,et al.  Dynamic Complexes of β2-Adrenergic Receptors with Protein Kinases and Phosphatases and the Role of Gravin* , 1999, The Journal of Biological Chemistry.

[24]  T Watanabe,et al.  Characterization of the Inhibition of Protein Phosphatase-1 by DARPP-32 and Inhibitor-2* , 1999, The Journal of Biological Chemistry.

[25]  M. Caron,et al.  A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. , 1997, The Journal of biological chemistry.

[26]  M. Lohse,et al.  Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. , 1995, Molecular pharmacology.

[27]  H. Sabbah,et al.  Inhibition of type 1 protein phosphatase activity by activation of beta-adrenoceptors in ventricular myocardium. , 2002, Biochemical pharmacology.

[28]  Estrella Foster,et al.  Differential phosphorylation and dephosphorylation of β2‐adrenoceptor sites Ser262 and Ser355,356 , 2006, British journal of pharmacology.

[29]  A. Seibold,et al.  β2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists* , 1997, The Journal of Biological Chemistry.

[30]  R. Lefkowitz,et al.  Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. , 1993, The Journal of biological chemistry.

[31]  P. Fishman,et al.  Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation. , 2004, The Journal of biological chemistry.

[32]  D. Stickle,et al.  Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase. , 1989, Molecular pharmacology.

[33]  David J. Vaughan,et al.  Role of the G Protein-coupled Receptor Kinase Site Serine Cluster in β2-Adrenergic Receptor Internalization, Desensitization, and β-Arrestin Translocation* , 2006, Journal of Biological Chemistry.

[34]  J L Benovic,et al.  Phosphorylation/dephosphorylation of the beta-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Sibley,et al.  Dephosphorylation of the beta 2-adrenergic receptor and rhodopsin by latent phosphatase 2. , 1988, The Journal of biological chemistry.

[36]  M. Caron,et al.  A Central Role for β-Arrestins and Clathrin-coated Vesicle-mediated Endocytosis in β2-Adrenergic Receptor Resensitization , 1997, The Journal of Biological Chemistry.

[37]  Julie A. Pitcher,et al.  The Role of Sequestration in G Protein-coupled Receptor Resensitization , 1997, The Journal of Biological Chemistry.

[38]  R. Lefkowitz,et al.  The G-protein-coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular distribution and substrate specificity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Milligan,et al.  Ligand regulation of green fluorescent protein‐tagged forms of the human β1‐ and β2‐adrenoceptors; comparisons with the unmodified receptors , 2000 .

[40]  M. Caron,et al.  Receptor-specific desensitization with purified proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin in the beta 2-adrenergic receptor and rhodopsin systems. , 1992, The Journal of biological chemistry.

[41]  B. J. Knoll,et al.  Salmeterol‐induced desensitization, internalization and phosphorylation of the human β2‐adrenoceptor , 1998, British journal of pharmacology.

[42]  B. J. Knoll,et al.  Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway. , 2000, Molecular pharmacology.

[43]  M. Caron,et al.  beta-Arrestin: a protein that regulates beta-adrenergic receptor function. , 1990, Science.

[44]  Wei Yang,et al.  Phosphorylation-independent Association of CXCR2 with the Protein Phosphatase 2A Core Enzyme* , 2001, The Journal of Biological Chemistry.

[45]  J. Benovic,et al.  The role of receptor kinases and arrestins in G protein-coupled receptor regulation. , 1998, Annual review of pharmacology and toxicology.